We have begun receiving supplies of Beyfortus, a single dose monoclonal antibody injection which offers protection against Respiratory Syncytial Virus (RSV). The CDC advises that ALL infants whose mother has not received an RSV vaccine and are under age 8 months entering their first RSV season (birthday March 1, 2024 or later) receive a single dose of Beyfortus from October 1 2024 through March 31, 2025.
Beyfortus is also recommended for a small group of children between 8 and 19 months who are at risk for severe RSV disease (premature infants with chronic lung disease; children severely immunocompromised; children with severe cystic fibrosis; Native American or Alaskan children).
The immunization should be given as part of the well visit and is safe to combine with any other recommended immunization, including COVID and Flu vaccine. Pregnant mothers are generally offered an RSV vaccine, Abrysvo, starting in September and when they are between 32 and 36 weeks of gestation. If a mother has received this vaccine at least 14 days prior to delivering, then her infant is considered protected and does not need to receive Beyfortus as well.
If your child does not have /what-is-beyfortus.jpg.aspx "what-is-beyfortus.jpg")
an upcoming well visit, then Beyfortus can be given as a nurse shot visit. Please SEND A PORTAL MESSAGE if you want to schedule a nurse appointment to receive Beyfortus. We will review your child's medical history to make sure they are recommended to receive Beyfortus, and then schedule your child for a nurse shot appointment.
This immunization has been covered by many private health insurance plans. Also, most cover the maternal RSV vaccine, but there may be a cost to you depending on your plan. As always, you should check with you insurance company to be sure the immunization is covered to avoid being assessed an out of pocket charge.